Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.
2.

No increased levels of the nicotine metabolite cotinine in smokers with schizophrenia.

Bozikas VP, Niopas I, Kafantari A, Kanaze FI, Gabrieli C, Melissidis P, Gamvrula K, Fokas K, Karavatos A.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jan;29(1):1-6. Epub 2004 Dec 8.

PMID:
15610938
3.

The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine.

Binnie V, McHugh S, Macpherson L, Borland B, Moir K, Malik K.

Oral Dis. 2004 Sep;10(5):287-93.

PMID:
15315646
4.

Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

Olincy A, Young DA, Freedman R.

Biol Psychiatry. 1997 Jul 1;42(1):1-5.

PMID:
9193735
5.

Saliva cotinine levels in smokers and nonsmokers.

Etter JF, Vu Duc T, Perneger TV.

Am J Epidemiol. 2000 Feb 1;151(3):251-8.

PMID:
10670549
6.
7.

[Smoking in adolescents, saliva cotinine concentrations and respiratory disease].

Suárez López de Vergara R, Galván Fernández C, Oliva Fernández C, Doménech Martínez E, Barroso Guerrero F.

An Esp Pediatr. 2001 Feb;54(2):114-9. Spanish.

PMID:
11181206
8.

Smoking characteristics and saliva cotinine levels in Taiwanese smokers: gender differences.

Huang CL, Lin HH, Yang YH.

J Clin Nurs. 2008 Sep;17(17):2367-74. doi: 10.1111/j.1365-2702.2008.02389.x.

PMID:
18705712
9.

Cotinine levels in Southeast Asian smokers.

Wewers ME, Ahijevych KL, Dhatt RK, Guthrie RM, Kuun P, Mitchell L, Moeschberger ML, Chen MS Jr.

Nicotine Tob Res. 2000 Feb;2(1):85-91.

PMID:
11072445
10.

The influence of gender, race, and menthol content on tobacco exposure measures.

Mustonen TK, Spencer SM, Hoskinson RA, Sachs DP, Garvey AJ.

Nicotine Tob Res. 2005 Aug;7(4):581-90.

PMID:
16085529
11.

Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type.

Blackford AL, Yang G, Hernandez-Avila M, Przewozniak K, Zatonski W, Figueiredo V, Avila-Tang E, Ma J, Benowitz NL, Samet JM.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1799-804. Epub 2006 Oct 4.

12.

Hubble-bubble (water pipe) smoking: levels of nicotine and cotinine in plasma, saliva and urine.

Shafagoj YA, Mohammed FI, Hadidi KA.

Int J Clin Pharmacol Ther. 2002 Jun;40(6):249-55.

PMID:
12078938
13.

[ELISA analysis of salivary cotinine in smokers].

Eramo S, Tassi C, Negri P, Manta M, Fraschini M, Pedetta F.

Minerva Stomatol. 2000 Apr;49(4):163-8. Italian.

PMID:
11040542
14.

Validity of self reports in a cohort of Swedish adolescent smokers and smokeless tobacco (snus) users.

Post A, Gilljam H, Rosendahl I, Meurling L, Bremberg S, Galanti MR.

Tob Control. 2005 Apr;14(2):114-7.

15.

Determinants of salivary cotinine level: a population-based study in Brazil.

Figueiredo VC, Szklo M, Szklo AS, Benowitz N, Lozana JA, Casado L, Masson E, Samet J.

Rev Saude Publica. 2007 Dec;41(6):954-62. Epub 2007 Dec 4.

16.
17.

Saliva cotinine and exhaled carbon monoxide levels in natural environment waterpipe smokers.

Bacha ZA, Salameh P, Waked M.

Inhal Toxicol. 2007 Jul;19(9):771-7.

PMID:
17613086
18.

[Environmental tobacco smoke exposure in pregnancy and postpartum period].

Polańska K, Hanke W, Sobala W, Ligocka D, Lowe J.

Przegl Lek. 2006;63(10):907-10. Polish.

PMID:
17288181
19.

Cotinine in an ultrafiltrate of saliva.

Schramm W, Pomerleau OF, Pomerleau CS, Grates HE.

Prev Med. 1992 Jan;21(1):63-73.

20.

[Cotinine--a useful biomarker for tobacco use?].

Suter PM, Spitzbarth A, Gautschi K, Erdmenger L, Vonderschmitt DJ, Vetter W.

Praxis (Bern 1994). 1995 Jul 18;84(29-30):821-5. German.

PMID:
7631097

Supplemental Content

Support Center